Novo Holdings has worked large Convatec investment for four years: "Things don't happen overnight"
Having been a large stakeholder in UK company Convatec for almost four years, Novo Holdings has yet to gain success from this investment. CEO Kasim Kutay stays optimistic.
BY BENJAMIN WERNER CHRISTENSEN & KASPER BRØNDGAARD ANDERSEN, TRANSLATED BY NIELSINE NIELSEN
The wealthy holding company Novo Holdings has burnt its fingers investing billions of kroner in medtech company Convatec.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Holdings beats records in 2020 and earns DKK 29bn
For subscribers
Leo Pharma's board now has one person less
For subscribers
FDA refuses to file Novo Nordisk application
For subscribers
